Reliable identification of pathogenic Burkholderia spp. like Burkholderia mallei and Burkholderia pseudomallei in clinical samples is desirable. Three different selective media were assessed for reliability and selectivity with various Burkholderia spp. and nontarget organisms.
Mast Burkholderia cepacia agar, Ashdown + gentamicin agar, and B. pseudomallei selective agar were compared. A panel of 116 reference strains and well-characterized clinical isolates, comprising 30 B. pseudomallei, 20 B. mallei, 18 other Burkholderia spp., and 48 nontarget organisms, was used for this assessment.
While all B. pseudomallei strains grew on all three tested selective agars, the other Burkholderia spp. showed a diverse growth pattern. Nontarget organisms, i.e., nonfermentative rod-shaped bacteria, other species, and yeasts, grew on all selective agars. Colony morphology did not allow unambiguous discrimination.
While the assessed selective media reliably allowed the growth of a wide range of B. pseudomallei strains, growth of other Burkholderia spp. is only partially ensured. Growth of various nontarget organisms has to be considered. Therefore, the assessed media can only be used in combination with other confirmative tests in the diagnostic procedure for the screening for melioidosis or glanders.
Gilad J : Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis. Recent Pat Antiinfect Drug Discov 2, 233–241 (2007)
Frickmann H , Chantratita N, Gauthier YP, Neubauer H, Hagen RM: Discrimination of Burkholderia mallei/pseudomallei from Burkholderia thailandensis by sequence comparison of a fragment of the ribosomal protein S21 (rpsU) gene. Eur J Microbiol Immunol (Bp) 2, 148–156 (2012)
Frickmann H , Neubauer H, Loderstaedt U, Derschum H, Hagen RM: rpsU-based discrimination within the genus Burkholderia. Eur J Microbiol Immunol (Bp) 4, 106–116 (2014)
Ostermann MF , Neubauer H, Frickmann H, Hagen RM: Correlation of rpsU gene sequence clusters and biochemical properties, GC-MS spectra and resistance profiles of clinical Burkholderia spp. isolates. Eur J Microbiol Immunol (Bp) 6, 25–39 (2016)
Frickmann H , Neubauer H, Haase G, Peltroche-Llacsahuanga H, Pérez-Bouza A, Racz P, Loderstaedt U, Hagen RM: Fatal urosepsis due to delayed diagnosis of genitourinary melioidosis. Laboratoriumsmedizin 37, 209–213 (2013)
Kingsley PV , Arunkumar G, Tipre M, Leader M, Sathiakumar N: Pitfalls and optimal approaches to diagnose melio idosis. Asian Pac J Trop Med 9, 515–524 (2016)
Hemarajata P , Baghdadi JD, Hoffman R, Humphries RM: Burkholderia pseudomallei: challenges for the clinical microbiology laboratory. J Clin Microbiol 54, 2866–2873 (2016)
Lau SK , Sridhar S, Ho CC, Chow WN, Lee KC, Lam CW, Yuen KY, Woo PC: Laboratory diagnosis of melioidosis: past, present and future. Exp Biol Med (Maywood) 240, 742–751 (2015)
Baldwin A , Mahenthiralingam E, Thickett KM, Honeybourne D, Maiden MC, Govan JR, Speert DP, LiPuma JJ, Vandamme P, Dowson CG: Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol 43, 4665–4673 (2005)
Lynch KH , Dennis JJ: Development of a species-specific fur gene-based method for identification of the Burkholderia cepacia complex. J Clin Microbiol 46, 447–455 (2008)
Papaleo MC , Perrin E, Maida I, Fondi M, Fani R, Vandamme P: Identification of species of the Burkholderia cepacia complex by sequence analysis of the hisA gene. J Med Microbiol 59, 1163–1170 (2010)
Payne GW , Vandamme P, Morgan SH, LiPuma JJ, Coenye T, Weightman AJ, Jones TH, Mahenthiralingam E: Development of a recA gene-based identification approach for the entire Burkholderia genus. Appl Env Microbiol 71, 3917–3927 (2005)
Cesarini S , Bevivino A, Tabacchioni S, Chiarini L, Dalmastri C: RecA gene sequence and multilocus sequence typing for species-level resolution of Burkholderia cepacia complex isolates. Lett Appl Microbiol 49, 580–588 (2009)
Karger A , Stock R, Ziller M, Elschner MC, Bettin B, Melzer F, Maier T, Kostrzewa M, Scholz HC, Neubauer H, Tomaso H: Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell matrix-assisted laser desorption/ionisation mass spectrometry typing. BMC Microbiol 12, 229 (2012)
Degand N , Carbonelle E, Dauphin B, Beretti JL, Le Bourgeois M, Sermet-Gaudelus I, Segonds C, Berche P, Nassif X, Ferroni A: Matrix-assisted laser desorption ionizationtime of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol 46, 3361–3367 (2008)
Vanlaere E , Sergeant K, Dawyndt P, Kallow W, Erhard M, Sutton H, Dare D, Devreese B, Samyn B, Vandamme P: Matrix-assisted laser desorption ionisation-time-of-flight mass spectrometry of intact cells allows rapid identification of Burkholderia cepacia complex. J Microbiol Methods 75, 279–286 (2008)
Minan A , Bosch A, Lasch P, Stammler M, Serra DO, Degrossi J, Gatti B, Vay C, D’aquino M, Yatorno O, Naumann D: Rapid identification of Burkholderia cepacia complex species including strains of the novel Taxon K, recovered from cystic fibrosis patients by intact cell MALDI-ToF mass spectrometry. Analyst 134, 1138–1148 (2009)
Micheel V , Hogan B, Köller T, Warnke P, Crusius S, Hinz R, Hagen RM, Schwarz NG, Frickmann H: Screening agars for MRSA: evaluation of a stepwise diagnostic approach with two different selective agars for the screening for methicillin-resistant Staphylococcus aureus (MRSA). Mil Med Res 2, 18 (2015)
Micheel V , Hogan B, Rakotoarivelo RA, Rakotozandrindrainy R, Razafimanatsoa F, Razafindrabe T, Rakotondrainiarivelo JP, Crusius S, Poppert S, Schwarz NG, May J, Frickmann H, Hagen RM: Identification of nasal colonization with ß-lactamase-producing Enterobacteriaceae in patients, health care workers and students in Madagascar. Eur J Microbiol Immunol (Bp) 5, 116–125 (2015)
Howard K , Inglis TJ: Novel selective medium for isolation of Burkholderia pseudomallei. J Clin Microbiol 41: 3312–3316 (2003)
Ashdown LR : An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology 11, 293–297 (1997)
Henry DA , Campbell ME, LiPuma JJ, Speert DP: Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol 35, 614–619 (1997)
Roesnita B , Tay ST, Puthucheary SD, Sam IC: Diagnostic use of Burkholderia pseudomallei selective media in a low prevalence setting. Trans R Soc Trop Med Hyg 106, 131–133 (2012)
Peacock SJ , Chieng G, Cheng AC, Dance DA, Amornchai P, Wongsuvan G, Teerawattanasook N, Chierakul W, Day NP, Wuthiekanun V: Comparison of Ashdown’s medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei. J Clin Microbiol 43, 5359–5361 (2005)
Glass MB , Beesley CA, Wilkins PP, Hoffmaster AR: Comparison of four selective media for the isolation of Burkholderia mallei and Burkholderia pseudomallei. Am J Trop Med Hyg 80, 1023–1028 (2009)
Vermis K , Vandamme PA, Nelis HJ: Burkholderia cepacia complex genomovars: utilization of carbon sources, susceptibility to antimicrobial agents and growth on selective media. J Appl Microbiol 95, 1191–1199 (2003)
Wright RM , Moore JE, Shaw A, Dunbar K, Dodd M, Webb K, Redmond AO, Crowe M, Murphy PG, Peacock S, Elborn JS: Improved cultural detection of Burkholderia cepacia from sputum in patients with cystic fibrosis. J Clin Pathol 54, 803–805 (2001)
Welch DF , Muszynski MJ, Pai CH, Marcon MJ, Hribar MM, Gilligan PH, Matsen JM, Ahlin PA, Hilman BC, Chartrand SA: Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol 25, 1730–1734 (1987)
Henry D , Campbell M, McGimpsey C, Clarke A, Louden L, Burns JL, Roe MH, Vandamme P, Speert D: Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 37: 1004–1007 (1999)
Cimolai N , Trombley C, Davidson AG, Wong LT: Selective media for isolation of Burkholderia (Pseudomonas) cepacia from the respiratory secretions of patients with cystic fibrosis. J Clin Pathol 48, 488–490 (1995)
Flanagan PG , Paull A: Isolation of Burkholderia cepacia by enrichment. J Clin Pathol 51, 557–558 (1998)
Raclavsky V , Novotny R: Burkholderia cepacia selective agar can be useful for recovery of Exophiala dermatitidis from sputum samples of cystic fibrosis patients. J Cyst Fibros 15, e19 (2016)
Hagen RM , Frickmann H, Elschner M, Melzer F, Neubauer H, Gauthier YP, Racz P, Poppert S: Rapid identification of Burkholderia pseudomallei and Burkholderia mallei by fluorescence in situ hybridization (FISH) from culture and paraffin-embedded tissue samples. Int J Med Microbiol 301, 585–590 (2011)
Karger A , Stock R, Ziller M, Elschner MC, Bettin B, Melzer F, Maier T, Kostrzewa M, Scholz HC, Neubauer H, Tomaso H: Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell matrix-assisted laser desorption/ionisation mass spectrometry typing. BMC Microbiol 12, 229 (2012)
Vanlaere E , Sergeant K, Dawyndt P, Kallow W, Erhard M, Sutton H, Dare D, Devreese B, Samyn B, Vandamme P: Matrix-assisted laser desorption ionisation-time-of-flight mass spectrometry of intact cells allows rapid identification of Burkholderia cepacia complex. J Microbiol Methods 75, 279–286 (2008)